ArcelorMittal S.A.: ArcelorMittal reports second quarter 2024 and half year 2024 results
August 01, 2024 01:00 ET
|
ArcelorMittal S.A.
Luxembourg, August 1, 2024 - ArcelorMittal (referred to as “ArcelorMittal” or the “Company” or the "Group") (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world’s leading integrated...
Santhera Appoints Dr. Oliver P. Kronenberg as Chief Legal Officer and Company Secretary
July 31, 2024 01:00 ET
|
Santhera Pharmaceuticals Holding AG
Dr. Kronenberg brings 25 years of legal experience, with 20 years in the pharmaceutical industry Oliver Strub appointed as Head of Compliance Pratteln, Switzerland, July 31, 2024 – Santhera...
Santhera ernennt Dr. Oliver P. Kronenberg zum Chief Legal Officer und Company Secretary
July 31, 2024 01:00 ET
|
Santhera Pharmaceuticals Holding AG
Dr. Kronenberg bringt 25 Jahre juristische Erfahrung mit, davon 20 Jahre in der PharmaindustrieOliver Strub wird zum Leiter der Compliance-Abteilung ernannt Pratteln, Schweiz, 31. Juli 2024 –...
Municipality Finance issues a EUR 50 million tap under its MTN programme
July 30, 2024 03:00 ET
|
Municipality Finance Plc
Municipality Finance PlcStock exchange release 30 July 2024 at 10:00 am (EEST) Municipality Finance issues a EUR 50 million tap under its MTN programme On 31 July 2024 Municipality Finance Plc...
Kuntarahoitus laskee liikkeeseen 50 miljoonan euron lisäyksen viitelainaan osana joukkovelkakirjalainaohjelmaa
July 30, 2024 03:00 ET
|
Kuntarahoitus Oyj
Kuntarahoitus OyjPörssitiedote30.07.2024 klo 10.00 Kuntarahoitus laskee liikkeeseen 50 miljoonan euron lisäyksen viitelainaan osana joukkovelkakirjalainaohjelmaa Kuntarahoitus Oyj laskee 31.07.2024...
European Commission approves Roche’s Vabysmo for treatment of retinal vein occlusion (RVO)
July 30, 2024 01:00 ET
|
F. Hoffmann-La Roche Ltd
Approval is based on data from two Phase III studies in branch and central retinal vein occlusion (RVO) showing early and sustained vision improvements non-inferior to aflibercept, and robust retinal...
Clariant delivers strong underlying margin improvement in the second quarter and increases 2024 profitability outlook to ~ 16 % EBITDA margin
July 30, 2024 01:00 ET
|
Clariant International Ltd
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR SECOND QUARTER / FIRST HALF YEAR | 2024 Q2 2024 sales decreased by 3 % organically in local currencies1 to...
FURTHER EXPANSION OF MARKET SHARE - SIKA POSTS RECORD RESULTS IN FIRST HALF OF THE YEAR
July 29, 2024 23:00 ET
|
Sika AG
Ad Hoc Announcement Pursuant to Article 53 of the SIX Exchange Regulation Listing Rules FURTHER EXPANSION OF MARKET SHARE - SIKA POSTS RECORD RESULTS IN FIRST HALF OF THE YEAR Sales of CHF...
WEITERER AUSBAU DER MARKTANTEILE - SIKA MIT REKORDERGEBNIS IM ERSTEN HALBJAHR
July 29, 2024 23:00 ET
|
Sika AG
Ad-Hoc-Mitteilung gemäss Artikel 53 des Kotierungsreglements der SIX Exchange Regulation WEITERER AUSBAU DER MARKTANTEILE - SIKA MIT REKORDERGEBNIS IM ERSTEN HALBJAHR Umsatz erstes Halbjahr von CHF...
21Shares Integrates Chainlink Proof of Reserve to Increase Transparency of the 21Shares Core Ethereum ETF (CETH)
July 29, 2024 10:00 ET
|
21Shares
NEW YORK, July 29, 2024 -- 21Shares US LLC ("21Shares"), an affiliate of 21Shares AG, one of the world’s largest issuers of crypto exchange traded products (ETPs), today announced that the firm has...